Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards ...
As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report highlighted the growing role of non-animal, science-driven testing methods in ...
In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...
The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...
Experts urge India to adopt non-animal methods for pre-clinical drug testing to enhance ethics, efficiency, and scientific relevance.
In my May 2020 CW column, I introduced a new test method for measuring the fracture toughness within the facesheet-to-core interface region of sandwich composites. This proposed test method, referred ...
Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
In future medicine, personalized computer models, so-called Virtual Human Twins, could help in the planning of individual therapies. Today already, human organs can be simulated on chips or in petri ...
A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results